Assignment of Assignor's Interest

Recorded: 2004-04-02 Received: 2004-04-06 Pages: 5

Assignors

MACEJAK, DENNIS

Executed: 2004-02-15

MCSWIGGEN, JAMES

Executed: 2004-02-20

BEIGELMAN, LEONID

Executed: 2004-02-27

Assignee

SIRNA THERAPEUTICS, INC.

2950 WILDERNESS PLACE, BOULDER, CO, 80301, UNITED STATES

Covered Properties (2)

Transflective Liquid Crystal Display Device

Application: 10/814,393 →

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Application: 10/667,271 →